| 货号 | 产品名称 | 规格 | 库存 | 价格 | 数量 | 购买 |
|---|---|---|---|---|---|---|
| KR0097 | TGFβR2/ TGFBR2, Human, Recombinant | 10ug |
+
-
|
|
| 分子量 | 42.6 kDa |
|---|---|
| 表观分子量 | 59 kDa |
| 片段与标签 | Thr23-Asp159 C-Fc |
| 生物活性 | Measured by its ability to inhibit TGF-beta1 activity on Mv-1-lu mink lung epithelial cells. The ED50 for this effect is typically 0.2-3.0 μg/ ml in the presence of 1 ng/ mL of recombinant human TGF-beta1. |
| 物种 | Human |
| 表达宿主 | Human Cells |
产品特性
| 纯度 | ＞95% as determined by reducing SDS-PAGE. |
|---|---|
| 内毒素 | ＜1.0 EU per µg as determined by LAL test. |
| 保存 | Lyophilized Protein should be stored at ＜ -20℃, though stable at room temperature for 3 weeks.Reconstituted Protein solution can be stored at 4-7℃ for 2-7 days.Aliquots of reconstituted samples are stable at ＜ -20℃ for 3 months |
产品介绍
TGFBR2 is a single-pass type I membrane Protein and contains one Protein kinase domain. TGFBR2 exsits as a heterodimeric complex with another Receptor Protein and binds TGF-beta. Signals triggered through the TGF-beta Receptor complex prompt various responses by the cell. One such response is to inhibit cell growth and division. Based on this action, the TGF-beta Receptor type 2 is sometimes called a tumor suppressor. Defects in TGFBR2 have been associated with Marfan syndrome, Loeys-Deitz aortic aneurysm syndrome, Osler-Weber-Rendu syndrome and the development of various types of tumors.
